On Caronia, Free Speech And Risk Mitigation

Posted On Thursday, March 7, 2013

When the Second Circuit ruled in December that drug manufacturers could not be prosecuted for promoting off-label uses of their products, we noted that the decision had “potentially...

read more

Categories